Shots:

• BioMarin will receive an exclusive license to each program for research- development- and commercialization of the gene therapies
• The collaboration will utilize Allen institute technologies to develop new gene therapies for rare genetic diseases of CNS by targeting gene expression to specific cells
• Allen Institute has developed modified engineering AAVs to carry genes on specific types of neurons or other cells in the brain

  Ref: BioMarin | Image: BioMarin